Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

By Di Pierro F, et al. Published June 24, 2021 in the International Journal of General Medicine Abstract Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing global pandemic known as COVID-19. Based on the potential...

read more
Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial

Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial

By Gilmar Reis, et al. PREPRINT August 23, 2021 ABSTRACT Background Recent evidence indicates a potential therapeutic role of fluvoxamine for COVID-19. In the TOGETHER randomized platform clinical trial for acutely symptomatic patients with COVID-19, we assessed...

read more
RAPID Clinical Trial Led by Unity Health Toronto Demonstrates Heparin May Help Moderately Ill & Hospitalized COVID-19 Patients

RAPID Clinical Trial Led by Unity Health Toronto Demonstrates Heparin May Help Moderately Ill & Hospitalized COVID-19 Patients

A multinational, multi-site team of researchers led by Peter Jüni of St. Michael’s Hospital and the University of Toronto in Canada investigated the efficacy of heparin as a treatment for moderate to severe SARS-CoV-2 infection, the virus behind the COVID-19 pandemic....

read more